CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to VRTX

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Drug Information

Target Indication

Cystic Fibrosis

Clinical Trial

NCT02392234

Last updated: 12/4/2025

Patent & Exclusivity
ActiveRLD

Latest Patent Expiry

Aug 27, 2033(6y 12m)

Patents Listed

28

Exclusivity

M-14NPPODE-435PEDODE-236ODE-338ODE-338PED

Application

NDA 207925
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.